Amedeo Smart

Free Medical Literature Service

 

Amedeo

Hypertension
  Free Subscription

Articles published in
JAMA
    April 2026
  1. ANDERER S
    Hypertension Burden Increasing Worldwide, With Stark Disparities.
    JAMA. 2026 Apr 17. doi: 10.1001/jama.2026.2114.
    >> Share

  2. ANDERER S
    Healthy Lifestyle Lowers Cardiometabolic Risk in People With Hypertension.
    JAMA. 2026 Apr 10. doi: 10.1001/jama.2026.2110.
    >> Share

    March 2026
  3. AZIZI M, Vongpatanasin W, Fisher NDL, Mahfoud F, et al
    Diagnosis and Management of Resistant Hypertension: A Review.
    JAMA. 2026 Mar 23. doi: 10.1001/jama.2026.1221.
    >> Share

  4. JOHNSON AE, Jackson CD, Alexander JT
    Management of Hypertension in Adults.
    JAMA. 2026 Mar 23. doi: 10.1001/jama.2026.1132.
    >> Share

    February 2026
  5. COHEN JB, Addo DK, Jacobs JA, Greene TH, et al
    Impact of a Smartwatch Hypertension Notification Feature for Population Screening.
    JAMA. 2026 Feb 9. doi: 10.1001/jama.2025.26925.
    >> Share

  6. HARDY ST, Jaeger BC, Emanuel E, Muntner P, et al
    Blood Pressure Above Goal Among US Adults With Hypertension.
    JAMA. 2026 Feb 2:e2525657. doi: 10.1001/jama.2025.25657.
    >> Share

    January 2026
  7. ANDERER S
    Combination Pills May Improve Hypertension.
    JAMA. 2026 Jan 23. doi: 10.1001/jama.2025.23034.
    >> Share

  8. JURASCHEK SP, Col H, Ferro K, Turkson-Ocran RN, et al
    DASH-Patterned Groceries and Effects on Blood Pressure: The GoFresh Randomized Clinical Trial.
    JAMA. 2026;335:36-48.
    >> Share

    December 2025
  9. PANT S
    Chronic Pain Linked to Hypertension.
    JAMA. 2025 Dec 12. doi: 10.1001/jama.2025.20022.
    >> Share

  10. ANDERER S
    Hypertension Among Children Has Increased Significantly.
    JAMA. 2025 Dec 5. doi: 10.1001/jama.2025.20012.
    >> Share

    November 2025
  11. MAYA J, Pant D, Fu Y, James K, et al
    Gestational Weight Gain and Pregnancy Outcomes After GLP-1 Receptor Agonist Discontinuation.
    JAMA. 2025 Nov 24:e2520951. doi: 10.1001/jama.2025.20951.
    >> Share

    October 2025
  12. TAI YH, Fu TC, Chang CM
    Lorundrostat for Uncontrolled Hypertension and Treatment-Resistant Hypertension.
    JAMA. 2025 Oct 22. doi: 10.1001/jama.2025.16167.
    >> Share

  13. SAXENA M, Rodman D
    Lorundrostat for Uncontrolled Hypertension and Treatment-Resistant Hypertension-Reply.
    JAMA. 2025 Oct 22. doi: 10.1001/jama.2025.16170.
    >> Share

    September 2025
  14. DESAI A, Havasi A, Saxena M
    Zilebesiran Add-On Treatment for Inadequately Controlled Hypertension-Reply.
    JAMA. 2025 Sep 24. doi: 10.1001/jama.2025.13329.
    >> Share

  15. CHEN T, Zhu Z
    Zilebesiran Add-On Treatment for Inadequately Controlled Hypertension.
    JAMA. 2025 Sep 24. doi: 10.1001/jama.2025.13326.
    >> Share

  16. ZHU J, Zhang W
    Timing of Antihypertensive Medications and Cardiovascular Outcomes.
    JAMA. 2025 Sep 17. doi: 10.1001/jama.2025.12790.
    >> Share

  17. GAO M, Cao T, Wu Q
    Timing of Antihypertensive Medications and Cardiovascular Outcomes.
    JAMA. 2025 Sep 17. doi: 10.1001/jama.2025.12787.
    >> Share

  18. GARRISON SR, Kolber MR, Korownyk CS
    Timing of Antihypertensive Medications and Cardiovascular Outcomes-Reply.
    JAMA. 2025 Sep 17. doi: 10.1001/jama.2025.12796.
    >> Share

  19. CEDERNAES J, Benedict C
    Timing of Antihypertensive Medications and Cardiovascular Outcomes.
    JAMA. 2025 Sep 17. doi: 10.1001/jama.2025.12784.
    >> Share

  20. FENG S, Li H, Sun R
    Timing of Antihypertensive Medications and Cardiovascular Outcomes.
    JAMA. 2025 Sep 17. doi: 10.1001/jama.2025.12793.
    >> Share

  21. XU Q, Gao Y, Zhang O
    Medications for Resistant Hypertension.
    JAMA. 2025 Sep 15. doi: 10.1001/jama.2025.12653.
    >> Share

  22. BROOK RD, Cohen JB, Rajagopalan S
    Medications for Resistant Hypertension-Reply.
    JAMA. 2025 Sep 15. doi: 10.1001/jama.2025.12656.
    >> Share

  23. GAO M, Cao T, Wu Q
    Hypertension Medications and Health-Related Quality of Life.
    JAMA. 2025 Sep 10. doi: 10.1001/jama.2025.12228.
    >> Share

  24. LEE CJ, Kim DH, Park S
    Hypertension Medications and Health-Related Quality of Life-Reply.
    JAMA. 2025 Sep 10. doi: 10.1001/jama.2025.12231.
    >> Share

    August 2025
  25. ANDERER S, Rekito A
    Hypertension Survey Finds Many US Adults Lack Key Knowledge of the Condition.
    JAMA. 2025 Aug 15. doi: 10.1001/jama.2025.13589.
    >> Share

  26. SCHNEIDER L
    Medication Timing Could Influence Hypertension Treatment.
    JAMA. 2025 Aug 1. doi: 10.1001/jama.2025.10983.
    >> Share

    June 2025
  27. SAXENA M, Laffin L, Borghi C, Fernandez Fernandez B, et al
    Lorundrostat in Participants With Uncontrolled Hypertension and Treatment-Resistant Hypertension: The Launch-HTN Randomized Clinical Trial.
    JAMA. 2025 Jun 30:e259413. doi: 10.1001/jama.2025.9413.
    >> Share

  28. ANDERER S
    Study Shows Decline in Hypertension Awareness Among US Adults.
    JAMA. 2025 Jun 27. doi: 10.1001/jama.2025.9633.
    >> Share

    May 2025
  29. DESAI AS, Karns AD, Badariene J, Aswad A, et al
    Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension: The KARDIA-2 Randomized Clinical Trial.
    JAMA. 2025 May 28:e256681. doi: 10.1001/jama.2025.6681.
    >> Share

  30. CHEBIB FT, Hanna C, Harris PC, Torres VE, et al
    Autosomal Dominant Polycystic Kidney Disease: A Review.
    JAMA. 2025;333:1708-1719.
    >> Share

  31. LEE CJ, Ihm SH, Shin DH, Jeong JO, et al
    Spironolactone vs Amiloride for Resistant Hypertension: A Randomized Clinical Trial.
    JAMA. 2025 May 14:e255129. doi: 10.1001/jama.2025.5129.
    >> Share

  32. BROOK RD, Cohen JB, Rajagopalan S
    New Support for Old Medications in Resistant Hypertension.
    JAMA. 2025 May 14. doi: 10.1001/jama.2025.4321.
    >> Share

  33. TALER SJ
    Morning or Nighttime Medication Dosing-Does It Matter in the Treatment of Hypertension?
    JAMA. 2025 May 12. doi: 10.1001/jama.2025.7286.
    >> Share

  34. GARRISON SR, Bakal JA, Kolber MR, Korownyk CS, et al
    Antihypertensive Medication Timing and Cardiovascular Events and Death: The BedMed Randomized Clinical Trial.
    JAMA. 2025 May 12:e254390. doi: 10.1001/jama.2025.4390.
    >> Share

    February 2025
  35. ANDERER S
    Supine Hypertension Linked to Cardiovascular Risk Regardless of Seated Blood Pressure.
    JAMA. 2025 Feb 21. doi: 10.1001/jama.2025.0544.
    >> Share

    January 2025
  36. ANDERER S
    Hypertensive Disorders of Pregnancy May Be Associated With Future Neurological Issues.
    JAMA. 2025 Jan 24. doi: 10.1001/jama.2024.28057.
    >> Share

    November 2024
  37. GARG AX, Cuerden MS, Sontrop JM
    Hypertension Risk and Kidney Function Following Kidney Donation-Reply.
    JAMA. 2024 Nov 20. doi: 10.1001/jama.2024.21430.
    >> Share

  38. LIN Y, Huang J
    Hypertension Risk and Kidney Function Following Kidney Donation.
    JAMA. 2024 Nov 20. doi: 10.1001/jama.2024.21427.
    >> Share

  39. ZHONG P, Liu X, Liao L
    Hypertension Risk and Kidney Function Following Kidney Donation.
    JAMA. 2024 Nov 20. doi: 10.1001/jama.2024.21424.
    >> Share

    October 2024
  40. ANDERER S
    More Than Half of US Adults With Uncontrolled Hypertension Don't Know They Have It.
    JAMA. 2024 Oct 11. doi: 10.1001/jama.2024.20117.
    >> Share

  41. ABBASI J
    Semaglutide Updates, Hypertension Triple Pills, and More-Heart Health Highlights From ESC Congress.
    JAMA. 2024 Oct 4. doi: 10.1001/jama.2024.19544.
    >> Share

    August 2024
  42. OJJI DB, Salam A, Sani MU, Ogah OS, et al
    Low-Dose Triple-Pill vs Standard-Care Protocols for Hypertension Treatment in Nigeria: A Randomized Clinical Trial.
    JAMA. 2024 Aug 31. doi: 10.1001/jama.2024.18080.
    >> Share

  43. MENSAH GA
    Is a Low-Dose Triple-Drug Combination Pill Protocol the Answer for Hypertension Control in Sub-Saharan Africa?
    JAMA. 2024 Aug 31. doi: 10.1001/jama.2024.18166.
    >> Share

    July 2024
  44. DIAO JA, Shi I, Murthy VL, Buckley TA, et al
    Projected Changes in Statin and Antihypertensive Therapy Eligibility With the AHA PREVENT Cardiovascular Risk Equations.
    JAMA. 2024 Jul 29:e2412537. doi: 10.1001/jama.2024.12537.
    >> Share

  45. HARRIS E
    Self-Monitoring and Managing Medications Improved High Blood Pressure.
    JAMA. 2024;332:7-8.
    >> Share

    June 2024
  46. BOCK A
    Antihypertensives Might Explain Some Older Adults' New Eczema Diagnoses.
    JAMA. 2024 Jun 21. doi: 10.1001/jama.2024.10347.
    >> Share

  47. HARRIS E
    Blood Pressure Drugs Linked to More Fractures, Falls in VA Nursing Homes.
    JAMA. 2024;331:1982.
    >> Share

  48. OGEDEGBE G, Teresi JA, Williams SK, Ogunlade A, et al
    Home Blood Pressure Telemonitoring and Nurse Case Management in Black and Hispanic Patients With Stroke: A Randomized Clinical Trial.
    JAMA. 2024 Jun 6. doi: 10.1001/jama.2024.6609.
    >> Share

    May 2024
  49. HARRIS E
    Swapping Salt for a Substitute May Lower Deaths, Reduce Heart Problems.
    JAMA. 2024;331:1698-1699.
    >> Share

  50. GARG AX, Arnold JB, Cuerden MS, Dipchand C, et al
    Hypertension and Kidney Function After Living Kidney Donation.
    JAMA. 2024 May 23. doi: 10.1001/jama.2024.8523.
    >> Share

    April 2024
  51. LI W
    Blood Pressure Self-Management After Hypertensive Pregnancy.
    JAMA. 2024;331:1156.
    >> Share

  52. KITT J, McManus RJ, Leeson P
    Blood Pressure Self-Management After Hypertensive Pregnancy-Reply.
    JAMA. 2024;331:1156-1157.
    >> Share

    March 2024
  53. HARRIS E
    Tirzepatide Lowered Blood Pressure in People With Obesity.
    JAMA. 2024;331:821.
    >> Share

  54. HARRIS E
    Weight Loss Surgery Managed Blood Pressure for People With Obesity.
    JAMA. 2024;331:725-726.
    >> Share

    February 2024
  55. ESTRADA RA, Auger WR, Sahay S
    Chronic Thromboembolic Pulmonary Hypertension.
    JAMA. 2024 Feb 26. doi: 10.1001/jama.2023.24265.
    >> Share

  56. SCHIFFRIN EL
    RNA Injection Every 6 Months to Improve Adherence and Lower Blood Pressure in Patients With Hypertension.
    JAMA. 2024 Feb 16. doi: 10.1001/jama.2023.26071.
    >> Share

  57. BAKRIS GL, Saxena M, Gupta A, Chalhoub F, et al
    RNA Interference With Zilebesiran for Mild to Moderate Hypertension: The KARDIA-1 Randomized Clinical Trial.
    JAMA. 2024 Feb 16. doi: 10.1001/jama.2024.0728.
    >> Share

  58. PALMA JA, Kaufmann H
    Pharmacologic Treatment for High BP and Risk of CVD.
    JAMA. 2024;331:530-531.
    >> Share

  59. JURASCHEK SP, Mukamal KJ
    Pharmacologic Treatment for High BP and Risk of CVD-Reply.
    JAMA. 2024;331:531-532.
    >> Share

    November 2023
  60. ELMALEH-SACHS A, Schwartz JL, Bramante CT, Nicklas JM, et al
    Obesity Management in Adults: A Review.
    JAMA. 2023;330:2000-2015.
    >> Share

  61. HARRIS E
    Remote Hypertension Monitoring Improved Medication Use, Raised Costs.
    JAMA. 2023 Nov 22. doi: 10.1001/jama.2023.22936.
    >> Share

  62. KITT J, Fox R, Frost A, Shanyinde M, et al
    Long-Term Blood Pressure Control After Hypertensive Pregnancy Following Physician-Optimized Self-Management: The POP-HT Randomized Clinical Trial.
    JAMA. 2023 Nov 11. doi: 10.1001/jama.2023.21523.
    >> Share

  63. GUPTA DK, Lewis CE, Varady KA, Su YR, et al
    Effect of Dietary Sodium on Blood Pressure: A Crossover Trial.
    JAMA. 2023 Nov 11. doi: 10.1001/jama.2023.23651.
    >> Share

    October 2023
  64. BYRD JB, Bisognano JD, Brook RD
    Treating Hypertension in Patients With Orthostatic Hypotension: Benefits vs Harms in the Era of Aggressive Blood Pressure Lowering.
    JAMA. 2023;330:1435-1436.
    >> Share

  65. JURASCHEK SP, Hu JR, Cluett JL, Ishak AM, et al
    Orthostatic Hypotension, Hypertension Treatment, and Cardiovascular Disease: An Individual Participant Meta-Analysis.
    JAMA. 2023;330:1459-1471.
    >> Share

  66. HARRIS E
    Majority of People Live With Uncontrolled Hypertension Worldwide.
    JAMA. 2023 Oct 4. doi: 10.1001/jama.2023.19204.
    >> Share

  67. SANCHEZ-DE-LA-TORRE M, Gracia-Lavedan E, Benitez ID, Sanchez-de-la-Torre A, et al
    Adherence to CPAP Treatment and the Risk of Recurrent Cardiovascular Events: A Meta-Analysis.
    JAMA. 2023;330:1255-1265.
    >> Share

    September 2023
  68. DENOBLE AE, Pettker CM
    Hypertension Screening in Pregnancy: Remembering the Basics, Charting the Future.
    JAMA. 2023;330:1040-1041.
    >> Share

  69. HENDERSON JT, Webber EM, Thomas RG, Vesco KK, et al
    Screening for Hypertensive Disorders of Pregnancy: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2023;330:1083-1091.
    >> Share

  70. BARRY MJ, Nicholson WK, Silverstein M, Cabana MD, et al
    Screening for Hypertensive Disorders of Pregnancy: US Preventive Services Task Force Final Recommendation Statement.
    JAMA. 2023;330:1074-1082.
    >> Share

  71. JIN J
    Screening for High Blood Pressure Disorders During Pregnancy.
    JAMA. 2023;330:1107.
    >> Share

  72. WILLIAMS B
    A New Dawn for Aldosterone as a Therapeutic Target in Hypertension.
    JAMA. 2023 Sep 10. doi: 10.1001/jama.2023.17087.
    >> Share

  73. LAFFIN LJ, Rodman D, Luther JM, Vaidya A, et al
    Aldosterone Synthase Inhibition With Lorundrostat for Uncontrolled Hypertension: The Target-HTN Randomized Clinical Trial.
    JAMA. 2023 Sep 10:e2316029. doi: 10.1001/jama.2023.16029.
    >> Share

  74. HARRIS E
    High Blood Pressure More Likely After COVID-19 Than Flu.
    JAMA. 2023 Sep 6. doi: 10.1001/jama.2023.16676.
    >> Share

  75. MISTRY EA, Hart KW, Davis LT, Gao Y, et al
    Blood Pressure Management After Endovascular Therapy for Acute Ischemic Stroke: The BEST-II Randomized Clinical Trial.
    JAMA. 2023;330:821-831.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016